John Fowler joined Piramal as Chief Operating Officer- Pharma Solutions, with responsibility for Operations and Research & Development (R&D) across all PPS sites in North America, Europe and Asia.John is responsible to strengthen our operational network, drive seamless integration of operations from early stage through life cycle management, and finally, align all our global network sites under the ‘One Piramal’ vision.
Over a distinguished career of nearly three decades, John has successfully led several global businesses, streamlined operations, developed and implemented commercial strategies that have increased profitability while driving growth, and has aligned focus of R&D with long term business requirements.
Most recently, John served as the Divisional CEO at Johnson Matthey (JM), with responsibility for JM’s Services (Custom API Development, Manufacturing, Catalyst & Chiral Technologies), and Products (Generics Development and Manufacturing) portfolio. Before leading JM’s Fine Chemical Division, John held senior leadership roles in several business verticals at JM, including Pharmaceutical Materials and Services, Environmental Catalysts and Technologies, among others. John has a Chemical Engineering degree from Bucknell University and an MBA from St. Joseph University.